Evidence map›Paper›PMID 30701622›Full record

ArticleAddiction (Abingdon, England)2019

Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.

Richard J O'Connor, Brian V Fix, Ann McNeill, Maciej L Goniewicz, Maansi Bansal-Travers, Bryan W Heckman, K Michael Cummings, Sara Hitchman, Ron Borland, David Hammond and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Comparing POD and MOD ENDS Users' Product Characteristics, Use Behaviors, and Nicotine Exposure.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Electronic Cigarette Terminology: Where Does One Generation End and the Next Begin?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  14. Nicotine content, labelling and flavours of e-liquids in Canada in 2020: a scan of the online retail market.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022
    Article
  15. Observational
  16. Article
  17. Gender Differences in Reasons for Using Electronic Cigarettes and Product Characteristics: Findings From the 2018 ITC Four Country Smoking and Vaping Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Richard J O'ConnorDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Brian V FixDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ann McNeillAddictions Department, Institute of Psychology, Psychiatry & Neuroscience, King's College London, London, UK.
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Bryan W HeckmanDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Sara HitchmanAddictions Department, Institute of Psychology, Psychiatry & Neuroscience, King's College London, London, UK.
Ron BorlandCancer Council Victoria, Melbourne, VIC, Australia.
David HammondSchool of Public Health and Health Systems, University of Waterloo, Melbourne, ON, Canada.
David LevyDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Georgetown, Washington, DC, Canada.
Shannon GravelyDepartment of Psychology, University of Waterloo, Waterloo, ON, Canada.
Geoffrey T FongSchool of Public Health and Health Systems, University of Waterloo, Melbourne, ON, Canada.
Roswell Park Comprehensive Cancer Center · USUniversity of Waterloo · CAAustralian Psychological Society · AUGeorgetown University · USKing's College London · GBMedical University of South Carolina · USMUSC Hollings Cancer Center · USOntario Institute for Cancer Research · CAUK Centre for Tobacco & Alcohol Studies · GB

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HAMMOND, DAVID · 2016 to 2025
$25.3M
Personalized Smoking Relapse Prevention Delivered in Real-Time via Just-in-time Adaptive InterventionsK23DA041616 · NIDA · MEHARRY MEDICAL COLLEGE · PI HECKMAN, BRYAN WAYNE · 2017 to 2021
$929k
CIHR FDN‐148477NCI NIH HHS P01 CA200512NIDA NIH HHS K23 DA041616
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe regulatory environment for nicotine vaping products (NVPs) varies widely across countries and this will probably affect the devices used, nicotine content and usage, and hence the ability of NVPs to substitute for cigarettes. We aimed to describe the types of NVPs used by current vapers in four countries with varying regulatory and enforcement approaches toward the marketing and sale of NVPs.

methodsData are from wave 1 (July-November 2016) of the ITC Four Country Smoking and Vaping Survey (4CV1), conducted among a cohort of current and former smokers, and current NVP users (n = 5147 adults; ≥ 18 years) in Australia (AU), Canada (CA), England (EN) and the United States (US) reporting either current daily, weekly or occasional NVP use. Devices were described by type, brand, voltage variability and refill capacity. Refill solutions were described by flavour and nicotine content. Descriptive statistics and bivariate analyses were conducted on the overall sample and stratified by country. A multinomial logistic regression examined factors associated with device preference across the whole sample.

resultsThe types of NVPs used differed by pattern of use and country. Exclusive, daily vapers were more likely to use refillable pen-shaped devices [odds ratio (OR) = 10.0] or refillable box-shaped devices (OR = 5.4) than disposable cigalike devices, when compared with other (non-daily/dual) users. Nearly all respondents reported using flavoured NVPs, fruit (28.3%) being the most common flavour. Refillable devices were the most popular: refillable box-shaped devices were more commonly reported by vapers in AU (36.8%) and US (31.4%), whereas in EN (47.4%) and CA (29.7%), vapers more often reported using refillable pen-style devices. Most users also reported that their products contained nicotine, even in CA (87.8%) and AU (91.2%), where vaping products containing nicotine were technically illegal.

conclusionsIn Australia, Canada, England and the United States in 2016, refillable nicotine vaping products were the most common type of nicotine vaping products used by daily vapers. Most daily vapers reported using flavoured e-liquids/refills (with variance across countries) and most reported using products that contain nicotine, even where vaping products with nicotine were banned.

Indexed as

Cross-Cultural ComparisonFlavoring AgentsNicotineAdolescentAdultAgedAustraliaCanadaCommerceEnglandFemaleHealth SurveysHumansMaleMiddle AgedSocial MarketingFlavoring AgentsNicotineAerosoldeliverydevicee-cigarettesflavournicotinevaporized nicotine products

Identifiers

PMID30701622
PMCPMC6669098
OpenAlexW2914251351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.